Premium
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.17 | 13.4920634921 | 1.26 | 1.54 | 1.25 | 162415 | 1.40674302 | CS |
| 4 | 0.24 | 20.1680672269 | 1.19 | 1.54 | 1.111 | 225799 | 1.36169839 | CS |
| 12 | 0.34 | 31.1926605505 | 1.09 | 1.75 | 0.92 | 317594 | 1.25432878 | CS |
| 26 | 0.76 | 113.432835821 | 0.67 | 1.9891 | 0.45 | 538976 | 1.23613806 | CS |
| 52 | -0.75 | -34.4036697248 | 2.18 | 2.37 | 0.45 | 442521 | 1.3019002 | CS |
| 156 | -5.09 | -78.0674846626 | 6.52 | 6.84 | 0.45 | 350299 | 2.59391647 | CS |
| 260 | -16.64 | -92.0863309353 | 18.07 | 35.5 | 0.45 | 340061 | 7.44537451 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
